Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 7, 2011

Premium

Jan Smilek has been named chief financial officer at Akonni Biosystems.

He most recently was CFO and treasurer of Sucampo Pharmaceuticals. He was also senior director of finance for Vanda Pharmaceuticals and served as a senior manager for PricewaterhouseCoopers.

Smilek holds a BS in economics from the School of Economics in Bratislava, Slovakia, and an MBA from Georgetown University.


Exosome Diagnostics has named new members to its scientific advisory board, including John Quackenbush, Bob Carter, Carlos Cordon-Cardo, and Keith Flaherty.

Quackenbush is a professor at Dana-Faber Cancer Institute's Department of Computational Biology and Bioinformatics. Carter is chief of neurosurgery at the University of California, San Diego; Cordon-Cardo is vice chairman of pathology and a professor of pathology and urology at Columbia University; and Flaherty is director of developmental therapeutics at the Massachusetts General Hospital Cancer Center.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.